Targeting one type of immune cell with another slows cancer growth in preclinical studies



Targeting one type of immune cell with another slows cancer growth in preclinical studies

A new approach to cancer immunotherapy that uses one type of immune cell to kill another — rather than directly attacking the cancer — provokes a robust anti-tumor immune response that shrinks ovarian, lung, and pancreatic tumors in preclinical disease models, according to researchers. The study involved a twist on a type of therapy that uses immune cells known as CAR T cells.

Materials provided by The Mount Sinai Hospital / Mount Sinai School of Medicine. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

31st March 2023

Form is (mal)function: Protein's shape lets bacteria disarm it

Read more
30th March 2023

Researchers discover a way to fight the aging process and cancer development

Read more
30th March 2023

Researchers identify cell type that could be key to preventing marrow transplant complication

Read more